Shuttle pharmaceuticals inc stock
WebAug-30-22 04:40PM. Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering. PR Newswire. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. WebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update in connection with …
Shuttle pharmaceuticals inc stock
Did you know?
Web1 day ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) WebFeb 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company ... WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
WebMar 9, 2024 · Game Changing Potential. Shuttle Pharmaceuticals is developing first-in-class therapies that are designed to cure cancer and improve the outcomes of patients receiving radiation therapy. Our focus is on products with unique properties to sensitize cancer cells, protect normal tissues and monitor clinical responses to treatment. WebMar 30, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, ... Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $1.18 and its highest was $126.26 in the past 12 months.
WebDec 29, 2024 · Shuttle Pharmaceuticals Holdings (NASDAQ: SHPH) is owned by 0.98% institutional shareholders, 72.32% Shuttle Pharmaceuticals Holdings insiders, and 26.70% retail investors. Anatoly Dritschilo is the largest individual Shuttle Pharmaceuticals Holdings shareholder, owning 7.49M shares representing 54.88% of the company.
WebMar 17, 2024 · Shuttle Pharmaceuticals Stock (NASDAQ:SHPH), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. lithium and clomipramineWebThe Company was originally founded as Shuttle Pharmaceuticals, LLC in December 2012 in the State of Maryland. In June 2024, Shuttle Pharmaceuticals, Inc. became a wholly owned subsidiary of Shuttle Pharmaceuticals Holdings, Inc., a State of Delaware corporation. improve technical knowledgelithium and creatinine clearanceWebMar 30, 2024 · Detailed statistics for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock, including valuation metrics, financial numbers, share information and more. lithium and dementiaWebMar 11, 2024 · Complete Shuttle Pharmaceuticals Holdings Inc. stock information by Barron's. View real-time SHPH stock price and news, along with industry-best analysis. lithium and clozaril interactionWebApr 6, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) NASDAQ: SHPH · IEX Real-Time Price · USD. Add to Watchlist 1.39-0.06 (-4.14%) At close: Apr 6, 2024, 4:00 PM. 1.38 ... No financial forecasts available for this stock Revenue Forecast. No data available. Revenue Growth. No data available. EPS Forecast. No data available. improve technical skills goalsWebMar 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company. It is focused on improving the outcomes of cancer patients treated with radiation therapy (RT). The Company by developing radiation sensitizers helps to increase cancer cure rates, prolong patient survival and improve … improve technical communication skills